
Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.
T
Read full storyThe Japan Times
Original source

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.
The Japan Times
Original source
Staffing levels are leading to issues like children not getting their medication on time and even dosing errors, the nurse said.
Fisher Funds is warning the Iran war dragging on could bring weakness to markets.

BusinessNZ wants corporate tax cut from 28% in staged reductions.

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer